Related Experiment Video
Updated: Oct 17, 2025

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Brief Behavioral Treatment for Insomnia: A Meta-Analysis
Misol Kwon1, Jia Wang2, Gregory Wilding2
1School of Nursing, University at Buffalo, State University of New York, Buffalo, NY.
Brief behavioral treatment for insomnia (BBTI) significantly improves sleep onset latency and wake after sleep onset in adults. This meta-analysis suggests BBTI is effective for middle-aged and older adults.
Area of Science:
- Sleep Medicine
- Behavioral Science
- Gerontology
Background:
- Insomnia is a prevalent sleep disorder affecting millions worldwide.
- Behavioral interventions are a cornerstone of insomnia treatment.
- Brief Behavioral Treatment for Insomnia (BBTI) offers a time-limited approach.
Purpose of the Study:
- To quantify the efficacy of BBTI through a meta-analysis.
- To evaluate BBTI's impact on key sleep parameters.
Main Methods:
- Systematic literature search for randomized controlled trials (RCTs) of BBTI.
- Inclusion of studies on adults aged 32-84, published up to February 2020.
- Analysis of sleep onset latency (SOL), wake after sleep onset (WASO), sleep efficiency (SE%), and total sleep time (TST).
Main Results:
- BBTI significantly reduced SOL at early follow-up.
- BBTI demonstrated significant improvement in WASO at early follow-up.
- BBTI showed statistically significant improvements in SE% at both early and late follow-ups.
Conclusions:
- BBTI is preliminarily efficacious for improving sleep in middle-aged and older adults.
- The findings support the use of BBTI in clinical practice for this demographic.
- Further research may explore long-term efficacy and specific patient subgroups.
More Related Videos
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
CNS Depressants: Barbiturates and Benzodiazepines
REM Sleep Behavior Disorder
RBD is significantly associated with...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...